Isolation of the bactericidal/permeability-increasing protein from polymorphonuclear leukocytes by reversible binding to target bacteria.

[1]  S. Carroll,et al.  Biochemical Characterization of Recombinant Fusions of Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing Protein , 1997, The Journal of Biological Chemistry.

[2]  P. Elsbach,et al.  p15s (15-kD antimicrobial proteins) are stored in the secondary granules of Rabbit granulocytes: implications for antibacterial synergy with the bactericidal/permeability-increasing protein in inflammatory fluids. , 1997, Blood.

[3]  Ofer Levy,et al.  Antibiotic proteins of polymorphonuclear leukocytes , 1996, European journal of haematology.

[4]  O. Levy,et al.  Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. , 1995, The Journal of clinical investigation.

[5]  P. Elsbach,et al.  Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli , 1994, Infection and immunity.

[6]  P. Elsbach,et al.  The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. , 1993, Immunobiology.

[7]  P. Elsbach,et al.  High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide , 1992, Infection and immunity.

[8]  P. Elsbach,et al.  Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. , 1992, The Journal of clinical investigation.

[9]  C. E. Ooi,et al.  Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteins. , 1990, The Journal of biological chemistry.

[10]  P. Elsbach,et al.  Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification. , 1989, Journal of immunology.

[11]  I. Olsson,et al.  Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. , 1987, Blood.

[12]  P. Elsbach,et al.  The role of intramembrane Ca2+ in the hydrolysis of the phospholipids of Escherichia coli by Ca2+-dependent phospholipases. , 1985, The Journal of biological chemistry.

[13]  P. Elsbach,et al.  Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria. , 1983, The Journal of clinical investigation.

[14]  A. Cross,et al.  Sensitivity of K1-Encapsulated Escherichia coli to Killing by the Bactericidal/Permeability-Increasing Protein of Rabbit and Human Neutrophils , 1982, Infection and immunity.

[15]  P. Elsbach,et al.  Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure. , 1980, The Journal of clinical investigation.

[16]  A. Schneider,et al.  Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. , 1979, The Journal of biological chemistry.

[17]  H. Odeberg,et al.  Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. , 1978, The Journal of biological chemistry.

[18]  M Tuszkiewicz,et al.  [Bacterial endotoxins]. , 1967, Polski tygodnik lekarski.